THE PHARMACOLOGICAL ACTIVITY OF KETOROLAC TROMETHAMINE

被引:0
|
作者
ROOKS, WH
机构
来源
PHARMACOTHERAPY | 1990年 / 10卷 / 06期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ketorolac tromethamine is a highly potent member of a class of compounds having both analgesic and antiinflammatory activity. In animal pain models using underlying inflammation, ketorolac markedly inhibited the pain response and increased the pain threshold; it did not exhibit any narcotic or central nervous system depressant effects. It was also active in rat models of acute and chronic inflammation and pyresis. These activities are mediated primarily by potent prostagladin cyclooxygenase inhibitory activity. Mild central nervous system and cardiovascular effects occurred only at doses far greater than those required for analgesic and antiinflammatory activity. Solutions of ketorolac tromethamine are not irritating. When given intramuscularly to rabbits (0.31-5% solutions), no drug-related irritation or changes in serum creatine phosphokinase were seen. The agent was not irritating when applied to the skin or eyes (< 0.5% solutions) of animals.
引用
收藏
页码:S30 / S32
页数:3
相关论文
共 50 条
  • [31] ERYTHROPOIETIN RESPONSE TO KETOROLAC TROMETHAMINE ADMINISTRATION IN RATS
    HOFF, KK
    ZAWADA, ET
    ALAVI, FK
    LEYSE, JW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 681 - 681
  • [32] Diffuse Alveolar Hemorrhage due to Ketorolac Tromethamine
    Marak, Creticus P.
    Alappan, Narendrakumar
    Shim, Chang
    Guddati, Achuta K.
    PHARMACOLOGY, 2013, 92 (1-2) : 11 - 13
  • [33] THE PHARMACOKINETICS OF POSTOPERATIVE INTRAVENOUS KETOROLAC TROMETHAMINE IN CHILDREN
    OLKKOLA, KT
    MAUNUKSELA, EL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (02) : 182 - 184
  • [34] Ketorolac tromethamine-induced acute pancreatitis
    Goyal, SB
    Goyal, RS
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (04) : 411 - 411
  • [35] Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation
    Sandoval, Helga P.
    Fernandez De Castro, Luis E.
    Vroman, David T.
    Solomon, Kerry D.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 22 (04) : 251 - 257
  • [36] Development and characterization of ketorolac tromethamine osmotic pump tablets
    Ali, A. A.
    Sayed, O. M.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2013, 23 (03) : 275 - 281
  • [37] FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLETS OF KETOROLAC TROMETHAMINE
    Reddy, K. Ramanji
    Jaya, S.
    Kavya, M.
    Madhu, Chandaka
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (02): : 938 - 951
  • [38] A STUDY OF THE COMPARATIVE EFFECTS ON RESPIRATION OF KETOROLAC TROMETHAMINE AND MORPHINE
    BRANDON, B
    MATTIE, H
    SPIERDIJK, J
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 119 - 119
  • [39] Effectiveness of Ketorolac Tromethamine in Prevention of Severe Retinopathy of Prematurity
    Giannantonio, Carmen
    Papacci, Patrizia
    Purcaro, Velia
    Cota, Francesco
    Tesfagabir, Mikael Ghennet
    Molle, Fernando
    Lepore, Domenico
    Baldascino, Antonio
    Romagnoli, Costantino
    JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2011, 48 (04) : 247 - 251
  • [40] CORNEAL PERMEABILITY OF KETOROLAC TROMETHAMINE WHEN FORMULATED WITH TOBRAMYCIN
    LIDGATE, DM
    FU, RC
    FLEITMAN, JS
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (11) : 1779 - 1795